Innovating Works

eVai

Financiado
A novel bioinformatics SaaS platform to identify and classify the pathogenicity...
A novel bioinformatics SaaS platform to identify and classify the pathogenicity of single genomic variants and oligogenic variant combinations for the diagnosis and treatment of genetic dise Genetic diseases affect +300 million individuals worldwide, resulting in 2.8 million new patients every year. The advent of Next Generation Sequencing (NGS) means it’s now possible to analyze the whole patient’s genome. However, v... ver más
31/03/2024
ENGENOME SRL
2M€
Presupuesto del proyecto: 2M€
ver más
Líder del proyecto
ENGENOME SRL No se ha especificado una descripción o un objeto social para esta compañía.
Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-03-31
HORIZON-EIC-2021-ACCELERATORCHALLENGES-01-01: Strategic Digital and Health Techno... Scope:The EIC Accelerator Challenges supports companies (principally start-ups and SMEs) to scale up...
Cerrada hace 2 años
0% 70% 100%